University Briefs

If scientific hurdles can be leaped and political pitfalls circumvented, then developing countries may one day benefit from a unique international effort to bring genetic engineenng to the Third World. In biologist Roger Beachy’s lab at Washington University in St. Louis, scientists from France’s Institute of Scientific Research for Development Through Cooperation (ORSTOM) are working to make cassava, a crop that feeds 800 million people in Africa and Latin America, resistant to dis

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

If scientific hurdles can be leaped and political pitfalls circumvented, then developing countries may one day benefit from a unique international effort to bring genetic engineenng to the Third World. In biologist Roger Beachy’s lab at Washington University in St. Louis, scientists from France’s Institute of Scientific Research for Development Through Cooperation (ORSTOM) are working to make cassava, a crop that feeds 800 million people in Africa and Latin America, resistant to disease. With the arrival of a German scientist last month, the team is now complete and expects to work together for the next two or three years. ORSTOM has never before sent scientists to another country to learn a technology, but after Beachy and plant virologist Claude Fauquet met in early 1987, they realized they wanted to work on this project together despite some rather formidable obstacles: the genetic composition of the cassava is not well-known and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies